Dr. Daruka Mahadevan, MD, PhD
Claim this profileMays Cancer Center
Area of expertise
Solid Tumors
Daruka Mahadevan, MD, PhD has run 5 trials for Solid Tumors. Some of their research focus areas include:
Lung Cancer
Daruka Mahadevan, MD, PhD has run 4 trials for Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Mays Cancer Center
UT Health San Antonio - Mays Cancer Center - Institute For Drug Development
Clinical Trials Daruka Mahadevan, MD, PhD is currently running
LNCB74
for Cancer
This is an open-label, phase 1, dose escalation and dose expansion study to determine safety and tolerability, and to determine the maximum tolerated dose and / or recommended phase 2 dose of LNCB74 in participants with advanced solid tumors.
Recruiting
1 award
Phase 1
5 criteria
PT217
for Small Cell Lung Cancer
This trial is testing a new antibody treatment called PT217 for patients with certain neuroendocrine cancers who haven't responded to usual treatments. PT217 helps the immune system target and destroy cancer cells by attaching to specific proteins on them.
Recruiting
1 award
Phase 1 & 2
More about Daruka Mahadevan, MD, PhD
Clinical Trial Related
3 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Daruka Mahadevan, MD, PhD has experience with
- Pembrolizumab
- SM08502
- PRJ1-3024
- DT2216
- Docetaxel
- Abiraterone
Breakdown of trials Daruka Mahadevan, MD, PhD has run
Lung Cancer
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daruka Mahadevan, MD, PhD specialize in?
Daruka Mahadevan, MD, PhD focuses on Solid Tumors and Lung Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is Daruka Mahadevan, MD, PhD currently recruiting for clinical trials?
Yes, Daruka Mahadevan, MD, PhD is currently recruiting for 2 clinical trials in San Antonio Texas. If you're interested in participating, you should apply.
Are there any treatments that Daruka Mahadevan, MD, PhD has studied deeply?
Yes, Daruka Mahadevan, MD, PhD has studied treatments such as Pembrolizumab, SM08502, PRJ1-3024.
What is the best way to schedule an appointment with Daruka Mahadevan, MD, PhD?
Apply for one of the trials that Daruka Mahadevan, MD, PhD is conducting.
What is the office address of Daruka Mahadevan, MD, PhD?
The office of Daruka Mahadevan, MD, PhD is located at: Mays Cancer Center, San Antonio, Texas 78229 United States. This is the address for their practice at the Mays Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.